Donor site raw area wounds present a difficult and challenging prognosis. Management of  donor site raw area wounds inflicted by the different kinds of mechanisms require different  regimes which are poles apart from the regimes used for any of the other wounds. In such  raw area wounds, there is extensive loss of plasma leading to shock while whole blood loss is  the cause of shock in other acute wounds. Even though the wounds are relatively clean after  initial debridement, death in extensive donor raw areas is mainly because of wound infection  and septicemia. Current techniques of wound care have significantly reduced the incidence of  invasive wound infections, altered the organisms causing the infections that do occur, increased  the interval between injury and the onset of infection, reduced the mortality associated with  infection, decreased the overall incidence of infection in such patients, and increased patient  survival.  Feracrylum, a water-soluble combination of partial ferrous salts (II and III) of polyacrylic  acid, is one of the chemical hemostatic agents and an antibacterial agent. Its molecular weight  ranges from 500,000 to 800,000 Daltons, which prevents systemic absorption and prevents  any negative effects on the liver, kidney, adrenals, cardiovascular, or hemostatic systems.  Feracrylum has antibacterial properties, which lowers the risk of wound infection.